Logo
  • About
  • Contact
  • (888) 441-8033

Oncocyte Corp. Keeping Its Eye On The Ball

Oncocyte Corp. (OCX) management is focused on two things, expansion and execution. With several upcoming events and milestones on the horizon, building significant shareholder value is the primary goal. These milestones include driving awareness and sales uptake for DetermaRx™...

View full release

Interfaith leaders promote dialogue and tackle misconceptions around the Swastika

The Coalition of Hindus of North America (CoHNA) and Heiwa Peace and Reconciliation Foundation of New York (Heiwa) co-sponsored a three-day event aimed at spreading awareness, encouraging dialogue, and developing a deeper understanding of the Swastika - a symbol held sacred by...

View full release

Intrinsic ID Launches PUF Cafe - New Forum to Advance Security Technology for IoT and Other Vertical Markets

SUNNYVALE, Calif.,– February 9, 2021 – Intrinsic ID, the world’s leading provider of Physical Unclonable Function (PUF) security IP for embedded systems, today launched PUF Cafe (at www.pufcafe.com), a website dedicated to advancing the state-of-the-art in PUF technology and e...

View full release

Clora acquires Legit.ai to accelerate talent acquisition across the life sciences industry

February 9, 2021, 07:00 AM Eastern Standard Time BOSTON -- Clora Inc., the best place to discover, build, and manage on-demand life science teams, announced today that it has acquired Legit.ai, an AI-powered expert network focused on biopharma expertise, in a cash and stock de...

View full release

GAN SYSTEMS SHIPS 20,000,000 GAN TRANSISTORS

OTTAWA, ONTARIO, February 8, 2021 – GaN Systems, the global leader in GaN (gallium nitride) power transistors, today announced the shipment of its 20 Millionth GaN transistor and that its factory partners are on schedule to complete a 40X capacity expansion in 2021. The capac...

View full release

COVAXX’s COVID-19 Vaccine, UB-612, Induced Neutralizing Antibodies in 100% of Participants During Phase 1 Clinical Trial

DALLAS, TX (Feb. 8, 2021) – COVAXX, a U.S. company developing UB-612, a multitope protein/synthetic peptide-based vaccine to fight COVID-19, today announced positive interim Phase 1 data from its open-label COVID-19 clinical trial conducted in Taiwan. This study which evaluate...

View full release

Lumotive’s “Mini-LiDAR Early Access Program” Accelerates Adoption of Tiny LiDAR in Smartphones and Other Devices

Seattle, WA – February 8, 2021 – Lumotive, a leading developer of scalable, solid-state LiDAR systems, today began accepting applications for its “Mini-LiDAR Early Access Program” (EAP) from qualified partners deploying extremely small form-factor LiDAR in smartphones, augment...

View full release

February National Poll: America Giving Biden a Chance; Split on Trump Impeachment

In the first Emerson College/7 News national poll since his inauguration, President Biden’s approval rating sits at 49% approval and 39% disapproval of the job that he has done as president. Biden’s approval is particularly high with those 18-29 (60% approval), and African Ame...

View full release

UGI ENCOURAGES RESIDENTS TO USE SAFE ENERGY PRACTICES DURING WINTER WEATHER

With an unsettled weather and cold temperatures forecast over the next week and significant snow accumulations already on the ground, UGI encourages residents to continue to be “winter-wise” by using safe practices when clearing ice and snow that could affect the operation of ...

View full release

Kintara Builds on Positive Data and Game-Changing Affiliation with GCAR

Kintara’s Participation in the GBM AGILE Study Explained at the GBM Summit Kintara’s VAL-083 has been selected to participate in the landmark GBM AGILE study. GBM AGILE is a platform trial designed to evaluate multiple therapies in newly-diagnosed and recurrent GBM. Its goals ...

View full release
  • « First
  • ‹ Prev
  • …
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • …
  • Next ›
  • Last »
©2026 Reportable, Inc.
Terms and Conditions | Privacy Policy